Nashville Biosciences

Nashville Biosciences accelerates R&D in the life sciences by providing access to one of the world’s largest integrated datasets combining longitudinal clinical records with genomic and imaging data. As a wholly owned subsidiary of Vanderbilt University Medical Center leveraging the BioVU® biobank and advanced informatics tools, it enables pharmaceutical companies to identify genetic associations relevant to disease risk modeling and drug target discovery. The company has played a key role in sequencing over 250,000 whole genomes as part of the Alliance for Genomic Discovery initiative with Illumina and major pharma partners.